8,9-Dehydroestradiol
8,9-Dehydroestradiol[edit]

8,9-Dehydroestradiol is a synthetic derivative of the naturally occurring hormone estradiol, which is a form of estrogen. This compound is characterized by the presence of a double bond between the 8th and 9th carbon atoms in the steroid structure, distinguishing it from estradiol.
Chemical Properties[edit]
8,9-Dehydroestradiol is a steroid with the molecular formula C__H__O_. The introduction of the double bond in the steroid nucleus alters its chemical properties and potentially its biological activity compared to estradiol. The compound retains the phenolic A-ring typical of estrogens, which is crucial for its interaction with the estrogen receptor.
Biological Activity[edit]
As a derivative of estradiol, 8,9-Dehydroestradiol is expected to interact with estrogen receptors, which are part of the nuclear receptor family of intracellular receptors. These receptors, when bound by an estrogenic compound, can influence the expression of specific genes involved in the regulation of reproductive and other physiological processes.
The modification in the steroid structure may affect the binding affinity and selectivity of 8,9-Dehydroestradiol for different estrogen receptor subtypes, such as ER_ and ER_. This can lead to variations in its estrogenic activity, potentially making it useful for specific therapeutic applications or as a tool in research.
Synthesis[edit]
The synthesis of 8,9-Dehydroestradiol involves the chemical modification of estradiol or its precursors. The introduction of the double bond can be achieved through various organic synthesis techniques, such as dehydrogenation reactions. These processes require careful control of reaction conditions to ensure the desired structural changes without affecting other parts of the molecule.
Applications[edit]
8,9-Dehydroestradiol may be used in scientific research to study the effects of structural modifications on estrogenic activity. It can serve as a model compound to explore the relationship between chemical structure and biological function in the context of estrogen receptor binding and activation.
In addition, understanding the properties of such derivatives can aid in the development of new pharmaceuticals with improved efficacy and safety profiles for conditions related to estrogen deficiency or excess.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian